Experts say not to overreact to data on PPI health risks

11/8/2009 | HealthDay News

Recent study data have indicated that acid reducing medications called proton pump inhibitors may lead to other serious health problems, but physicians urge patients not to overreact. Gastroenterologist Dr. David Johnson said the studies so far don't "clearly implicate" PPIs and fail to weigh the benefits of treatment against any potential risk.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN